These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
72 related items for PubMed ID: 12357696
21. Increased DHEAS levels in patients with rheumatoid arthritis after treatment with tumor necrosis factor antagonists: evidence for improved adrenal function. Ernestam S, Hafström I, Werner S, Carlström K, Tengstrand B. J Rheumatol; 2007 Jul; 34(7):1451-8. PubMed ID: 17477470 [Abstract] [Full Text] [Related]
22. Treatment with tumour necrosis factor alpha antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies. Jonsdottir T, Forslid J, van Vollenhoven A, Harju A, Brannemark S, Klareskog L, van Vollenhoven RF. Ann Rheum Dis; 2004 Sep; 63(9):1075-8. PubMed ID: 15066863 [Abstract] [Full Text] [Related]
23. Do the clinical responses and complications following etanercept or infliximab therapy predict similar outcomes with the other tumor necrosis factor-alpha antagonists in patients with rheumatoid arthritis? Ang HT, Helfgott S. J Rheumatol; 2003 Nov; 30(11):2315-8. PubMed ID: 14677170 [Abstract] [Full Text] [Related]
27. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report. Catrina AI, Trollmo C, af Klint E, Engstrom M, Lampa J, Hermansson Y, Klareskog L, Ulfgren AK. Arthritis Rheum; 2005 Jan 10; 52(1):61-72. PubMed ID: 15641091 [Abstract] [Full Text] [Related]
28. [Remission--therapy goal in rheumatoid arthritis]. Z Rheumatol; 2007 Feb 10; 66(1):2 p following 87. PubMed ID: 17896425 [No Abstract] [Full Text] [Related]